BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38698005)

  • 1. Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study.
    Liu W; Xu Y; Yang L; Zhan S; Pang K; Lin H; Qin H; Zhang P
    Sci Rep; 2024 May; 14(1):10108. PubMed ID: 38698005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease.
    Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy and Safety of Surgical Treatment for Patients With Tuberculosis Destroyed Lung With or Without Chronic Pulmonary Aspergillosis.
    Ruan H; Gong C; Wang J
    World J Surg; 2021 May; 45(5):1595-1601. PubMed ID: 33558999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine pulmonary function test can estimate the extent of tuberculous destroyed lung.
    Lee EJ; Lee SY; In KH; Yoo SH; Choi EJ; Oh YW; Park S
    ScientificWorldJournal; 2012; 2012():835031. PubMed ID: 22666158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculous-destroyed lung: cardiovascular CT findings and prognostic imaging factors.
    Lee SW; Shim SS; Ryu YJ; Kim Y
    Clin Imaging; 2013; 37(6):1000-5. PubMed ID: 24055145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Mortality in Patients with Tuberculous Destroyed Lung Receiving Mechanical Ventilation.
    Kim WY; Kim MH; Jo EJ; Eom JS; Mok J; Kim KU; Park HK; Lee MK; Lee K
    Tuberc Respir Dis (Seoul); 2018 Jul; 81(3):247-255. PubMed ID: 29926549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of D-dimer in predicting pulmonary embolism in tuberculous pleural effusion patients.
    Li X; Qin Y; Ye W; Chen X; Sun D; Guo X; Gu W
    BMC Pulm Med; 2021 May; 21(1):177. PubMed ID: 34022828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tiotropium inhaler use on mortality in patients with tuberculous destroyed lung: based on linkage between hospital and nationwide health insurance claims data in South Korea.
    Kim HC; Kim TH; Kim YJ; Rhee CK; Oh YM
    Respir Res; 2019 May; 20(1):85. PubMed ID: 31060621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with venous thromboembolism in tuberculosis: A case control study.
    Nan GY; Fei H; Zhen W; Yun DT
    Clin Respir J; 2022 Dec; 16(12):835-841. PubMed ID: 36344481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Fibrinogen Degradation Products and D-Dimer in the Differential Diagnosis of Pulmonary Tuberculosis and Community-Acquired Pneumonia.
    Min W; Zi-Feng J; Jian-Lin X; Hao-Hui F
    Clin Lab; 2018 Jan; 64(1):135-140. PubMed ID: 29479876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of tuberculous destroyed lung in Nigeria.
    Adebonojo SA; Adebo OA; Osinowo O; Grillo IA
    J Natl Med Assoc; 1981 Jan; 73(1):39-42. PubMed ID: 7463493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of low-dose computed tomography to assess pulmonary tuberculosis among healthcare workers in a tuberculosis hospital.
    He W; Chen BD; Lv Y; Zhou Z; Xu JP; Lv PX; Zhou XH; Ning FG; Li CH; Wang DP; Zheng J
    Infect Dis Poverty; 2017 Mar; 6(1):68. PubMed ID: 28335802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a model for the differential diagnosis of non-tuberculous mycobacterial lung disease and pulmonary tuberculosis: A case-control study based on immunological and radiological features.
    Liu Q; Pan X; An H; Du J; Li X; Sun W; Gao Y; Li Y; Niu H; Gong W; Liang J
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111064. PubMed ID: 37857122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung.
    Ruan H; Liu F; Han M; Gong C
    BMC Pulm Med; 2021 Aug; 21(1):273. PubMed ID: 34419012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors of Tuberculosis Destroyed Lung in Patients with Pulmonary Tuberculosis and Structural Lung Diseases: A Retrospective Observational Study.
    Liu L; Wang X; Luo L; Liu X; Chen J
    Risk Manag Healthc Policy; 2024; 17():753-762. PubMed ID: 38567384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung.
    Ryu YJ; Lee JH; Chun EM; Chang JH; Shim SS
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):246-50, i. PubMed ID: 21219689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year prognosis and the role of brain natriuretic peptide levels in patients with chronic cor pulmonale.
    Park SY; Lee CY; Kim C; Jang SH; Park YB; Park S; Hwang YI; Lee MG; Jung KS; Kim DG
    J Korean Med Sci; 2015 Apr; 30(4):442-9. PubMed ID: 25829812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for respiratory failure after tuberculosis-destroyed lung surgery and increased dyspnea score at 1-year follow-up.
    Ruan H; Li Y; Wang Y; Liu F; Hou D; Gong C; Wang J; Liu Z
    J Thorac Dis; 2022 Oct; 14(10):3737-3747. PubMed ID: 36389307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the diagnostic efficacy of
    Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
    Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.